Hot -view biological disclosure 2022 semi -annual report achieved revenue of 2.046 billion yuan
Author:Capital state Time:2022.08.28
On August 25, hot -ora -view biological (code: 688068.SH) released the 2022 semi -annual performance report.
From January 1, 2022-June 30, 2022, the company realized operating income of 2.046 billion yuan, a year-on-year decrease of 43.17%, net profit of 815 million yuan, a year-on-year decrease of 43.91%, and the basic earnings per share were 8.85 yuan.
The company's industry is a medical device.
During the company's reporting period, the total assets at the end of the period were 3.856 billion yuan, the operating profit was 979 million yuan, the accounts receivable were 70.1961 million yuan, and the net cash flow generated by operating activities was 454 million yuan.Cash is 1.938 billion yuan.
Hot -view biological, the company's full name Beijing Hot -view Biotechnology Co., Ltd., was established on June 23, 2005. The current general manager Lin Changqing. The main business is a high -tech enterprise engaged in R & D, production and sales of internal diagnostic reagents and instruments.
- END -
The rural revitalization road starting from 85 cows
Shanxi Economic Daily reporter Changxue
At the end of June, Xinjiang's social financing scale reached 4.2 trillion yuan
Tianshan Network Quickly News reporter learned from the press conference of the People's Government of the Autonomous Region on July 29 that as of the end of June, the stock of social financing in Xin...